• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水溶性药物盐酸环丙沙星的固体脂质纳米粒

Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride.

作者信息

Shah M, Agrawal Y K, Garala K, Ramkishan A

机构信息

Gujarat Forensic Sciences University, Institute of Research and Development, Near Police Bhavan, Sector 18A, Gandhinagar-382 007, India.

出版信息

Indian J Pharm Sci. 2012 Sep;74(5):434-42. doi: 10.4103/0250-474X.108419.

DOI:10.4103/0250-474X.108419
PMID:23716872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3660870/
Abstract

The aim of this study was to understand and investigate the relationship between experimental factors and their responses in the preparation of ciprofloxacin hydrochloride based solid lipid nanoparticles. A quadratic relationship was studied by developing central composite rotatable design. Amount of lipid and drug, stirring speed and stirring time were selected as experimental factors while particle size, zeta potential and drug entrapment were used as responses. Prior to the experimental design, a qualitative prescreening study was performed to check the effect of various solid lipids and their combinations. Results showed that changing the amount of lipid, stirring speed and stirring time had a noticeable influence on the entrapment efficiencies and particle size of the prepared solid lipid nanoparticles. The particle size of a solid lipid nanoparticle was in the range of 159-246 nm and drug encapsulation efficiencies were marginally improved by choosing a binary mixture of physically incompatible solid lipids. Release of ciprofloxacin hydrochloride from solid lipid nanoparticle was considerably slow, and it shows Higuchi matrix model as the best fitted model. Study of solid lipid nanoparticle suggested that the lipid based carrier system could potentially be exploited as a delivery system with improved drug entrapment efficiency and controlled drug release for water soluble actives.

摘要

本研究的目的是了解和研究在制备盐酸环丙沙星固体脂质纳米粒过程中实验因素与其响应之间的关系。通过开展中心复合旋转设计研究了二次关系。脂质和药物的用量、搅拌速度和搅拌时间被选为实验因素,而粒径、ζ电位和药物包封率则用作响应指标。在进行实验设计之前,开展了一项定性预筛选研究,以检验各种固体脂质及其组合的效果。结果表明,改变脂质用量、搅拌速度和搅拌时间对所制备的固体脂质纳米粒的包封效率和粒径有显著影响。固体脂质纳米粒的粒径在159 - 246 nm范围内,通过选择物理不相容的固体脂质二元混合物,药物包封效率略有提高。盐酸环丙沙星从固体脂质纳米粒中的释放相当缓慢,并且显示Higuchi基质模型为最佳拟合模型。对固体脂质纳米粒的研究表明,基于脂质的载体系统有可能被开发为一种具有更高药物包封效率和可控药物释放的水溶性活性成分递送系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/3918047f8281/IJPhS-74-434-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/317123c9879c/IJPhS-74-434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/721ce5f51df0/IJPhS-74-434-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/246ae25c007f/IJPhS-74-434-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/cb9e8ee82785/IJPhS-74-434-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/dd18b02c78c3/IJPhS-74-434-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/3918047f8281/IJPhS-74-434-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/317123c9879c/IJPhS-74-434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/721ce5f51df0/IJPhS-74-434-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/246ae25c007f/IJPhS-74-434-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/cb9e8ee82785/IJPhS-74-434-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/dd18b02c78c3/IJPhS-74-434-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/3660870/3918047f8281/IJPhS-74-434-g015.jpg

相似文献

1
Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride.水溶性药物盐酸环丙沙星的固体脂质纳米粒
Indian J Pharm Sci. 2012 Sep;74(5):434-42. doi: 10.4103/0250-474X.108419.
2
Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery.用于药物递送的载盐酸环丙沙星的蛋白质、脂质和壳聚糖纳米颗粒的比较。
J Biomed Mater Res B Appl Biomater. 2008 Jul;86(1):105-12. doi: 10.1002/jbm.b.30994.
3
Ciprofloxacin hydrochloride-loaded glyceryl monostearate nanoparticle: factorial design of Lutrol F68 and Phospholipon 90G.盐酸环丙沙星载甘油单硬脂酸纳米粒:Lutrol F68 和 Phospholipon 90G 的析因设计。
J Microencapsul. 2012;29(4):331-43. doi: 10.3109/02652048.2011.651498. Epub 2012 Jan 18.
4
Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.通过十二指肠内递送富马酸喹硫平实现淋巴靶向的固体脂质纳米粒方法。
Curr Drug Deliv. 2018;15(6):818-828. doi: 10.2174/1567201814666170525121049.
5
Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design.采用 Box-Behnken 设计研制并优化氯霉素眼用固体脂质纳米粒制剂。
Int J Nanomedicine. 2011;6:683-92. doi: 10.2147/IJN.S17386. Epub 2011 Apr 6.
6
Development and optimization of solid lipid nanoparticles of amikacin by central composite design.采用中心复合设计法研制并优化阿米卡星固体脂质纳米粒。
J Liposome Res. 2010 Jun;20(2):97-104. doi: 10.3109/08982100903103904.
7
Systematic Development of Sertraline Loaded Solid Lipid Nanoparticle (SLN) by Emulsification-Ultrasonication Method and Pharmacokinetic Study in Sprague-Dawley Rats.采用乳化-超声法系统研制舍曲林负载固体脂质纳米粒(SLN)及其在Sprague-Dawley大鼠中的药代动力学研究。
Pharm Nanotechnol. 2019;7(2):162-176. doi: 10.2174/2211738507666190327145628.
8
Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.第二代脂质纳米粒(NLC)作为盐酸乐卡地平的口服药物载体。
Colloids Surf B Biointerfaces. 2014 Apr 1;116:81-7. doi: 10.1016/j.colsurfb.2013.12.012. Epub 2013 Dec 30.
9
Duloxetine HCl lipid nanoparticles: preparation, characterization, and dosage form design.盐酸度洛西汀盐酸盐脂质纳米粒:制备、表征和剂型设计。
AAPS PharmSciTech. 2012 Mar;13(1):125-33. doi: 10.1208/s12249-011-9727-6. Epub 2011 Dec 14.
10
Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment.环丙沙星固体脂质纳米粒:表征、体外释放及抗菌活性评估
Biomed Res Int. 2017;2017:2120734. doi: 10.1155/2017/2120734. Epub 2017 Jan 17.

引用本文的文献

1
The role of lipid particle-laden interfaces in regulating the co-delivery of two hydrophobic actives from o/w emulsions.载脂微粒界面在调控 O/W 乳液中两种疏水性活性物质共递送中的作用。
Drug Deliv. 2024 Dec;31(1):2425158. doi: 10.1080/10717544.2024.2425158. Epub 2024 Nov 8.
2
Menadione Sodium Bisulfite Loaded Rhamnolipid Based Solid Lipid Nanoparticle as Skin Lightener Formulation: A Green Production Beside In Vitro/In Vivo Safety Index Evaluation.基于鼠李糖脂的亚硫酸氢钠甲萘醌负载型固体脂质纳米粒作为皮肤美白制剂:绿色生产及体外/体内安全性指标评估
Adv Pharm Bull. 2024 Oct;14(3):623-633. doi: 10.34172/apb.2024.047. Epub 2024 Jun 22.
3

本文引用的文献

1
Nanoparticulate strategies for effective delivery of poorly soluble therapeutics.用于有效递送难溶性治疗药物的纳米颗粒策略。
Ther Deliv. 2010 Jul;1(1):149-67. doi: 10.4155/tde.10.4.
2
Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design.采用 Box-Behnken 设计研制并优化氯霉素眼用固体脂质纳米粒制剂。
Int J Nanomedicine. 2011;6:683-92. doi: 10.2147/IJN.S17386. Epub 2011 Apr 6.
3
Recent applications of liposomes in ophthalmic drug delivery.脂质体在眼科药物递送中的最新应用。
Liposomes to Cubosomes: The Evolution of Lipidic Nanocarriers and Their Cutting-Edge Biomedical Applications.
从脂质体到立方脂质体:脂质纳米载体的演变及其在生物医学中的前沿应用。
ACS Appl Bio Mater. 2024 May 20;7(5):2677-2694. doi: 10.1021/acsabm.4c00153. Epub 2024 Apr 13.
4
Compritol-based solid lipid nanoparticles of desvenlafaxine prepared by ultrasonication-assisted hot-melt encapsulation to modify its release.超声辅助热熔包封制备基于 Compritol 的去氨文拉法辛固体脂质纳米粒以修饰其释放。
Nanomedicine (Lond). 2024;19(11):965-978. doi: 10.2217/nnm-2023-0229. Epub 2024 Apr 9.
5
Emphasis on Nanostructured Lipid Carriers in the Ocular Delivery of Antibiotics.抗生素眼部递送中纳米结构脂质载体的研究重点。
Pharm Nanotechnol. 2024;12(2):126-142. doi: 10.2174/2211738511666230727102213.
6
Prodrug approaches for the development of a long-acting drug delivery systems.前药方法在长效药物传递系统开发中的应用。
Adv Drug Deliv Rev. 2023 Jul;198:114860. doi: 10.1016/j.addr.2023.114860. Epub 2023 May 7.
7
Solid Self-Nano Emulsifying Nanoplatform Loaded with Tamoxifen and Resveratrol for Treatment of Breast Cancer.负载他莫昔芬和白藜芦醇的固体自纳米乳化纳米平台用于乳腺癌治疗
Pharmaceutics. 2022 Jul 18;14(7):1486. doi: 10.3390/pharmaceutics14071486.
8
Development and Optimization of Ciprofloxacin HCl-Loaded Chitosan Nanoparticles Using Box-Behnken Experimental Design.盐酸环丙沙星载壳聚糖纳米粒的 Box-Behnken 实验设计的开发与优化。
Molecules. 2022 Jul 13;27(14):4468. doi: 10.3390/molecules27144468.
9
Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation.用于药物递送的纳米载体:重点关注维生素D和K转运的概述
Nanomaterials (Basel). 2022 Apr 17;12(8):1376. doi: 10.3390/nano12081376.
10
Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active.用于包封模型疏水性活性成分的固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC)的制剂设计、生产及特性研究
Food Hydrocoll Health. 2021;1:None. doi: 10.1016/j.fhfh.2021.100024.
J Drug Deliv. 2011;2011:863734. doi: 10.1155/2011/863734. Epub 2011 Mar 1.
4
Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer.5-氟尿嘧啶固体脂质纳米粒的优化:治疗结肠癌的初步研究。
Int J Med Sci. 2010 Nov 22;7(6):398-408. doi: 10.7150/ijms.7.398.
5
Production & stability of stavudine solid lipid nanoparticles--from lab to industrial scale.司他夫定固体脂质纳米粒的制备及稳定性——从实验室到工业规模。
Int J Pharm. 2011 Sep 20;416(2):461-70. doi: 10.1016/j.ijpharm.2010.08.014. Epub 2010 Aug 18.
6
Non-destructive methods of characterization of risperidone solid lipid nanoparticles.利培酮固体脂质纳米粒的非破坏性特征描述方法。
Eur J Pharm Biopharm. 2010 Sep;76(1):127-37. doi: 10.1016/j.ejpb.2010.05.003. Epub 2010 May 12.
7
Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine.水溶性药物齐多夫定的固体脂质纳米粒的制备与评价
Chem Pharm Bull (Tokyo). 2010 May;58(5):650-5. doi: 10.1248/cpb.58.650.
8
Optimization of subcritical fluid extraction of bioactive compounds using Hansen solubility parameters.利用 Hansen 溶解度参数优化亚临界流体提取生物活性化合物。
J Food Sci. 2009 Aug;74(6):E342-54. doi: 10.1111/j.1750-3841.2009.01251.x.
9
Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.通过脂质纳米颗粒改善亲水性肽药物包封的策略。
Colloids Surf B Biointerfaces. 2009 May 1;70(2):248-53. doi: 10.1016/j.colsurfb.2008.12.031. Epub 2008 Dec 31.
10
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.使用包裹在固体脂质纳米颗粒中的抗癌药物进行化疗。
Adv Drug Deliv Rev. 2007 Jul 10;59(6):491-504. doi: 10.1016/j.addr.2007.04.008. Epub 2007 May 1.